Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Myelodysplastic Syndromes 107Lymphoma, Non-Hodgkin 90Leukemia, Lymphocytic, Chronic, B-Cell 85Hodgkin Disease 84Leukemia 81Multiple Myeloma 80Lymphoma, Mantle-Cell 63Lymphoma 63Lymphoma, Follicular 59Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 50Lymphoma, Large B-Cell, Diffuse 49Hematologic Neoplasms 42Congenital Abnormalities 42Lymphoma, Large-Cell, Immunoblastic 36Leukemia, Myeloid, Accelerated Phase 35Leukemia, Myeloid, Chronic-Phase 34Anemia, Refractory, with Excess of Blasts 34Waldenstrom Macroglobulinemia 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 32Lymphoma, Large-Cell, Anaplastic 28Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Dendritic Cell Sarcoma, Interdigitating 26

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 5trametinib 3fludarabine 3dabrafenib 3Tacrolimus 3Melphalan 3Cyclophosphamide 3Busulfan 3ulixertinib 2tipifarnib 2thymoglobulin 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fludarabine phosphate 2erdafitinib 2ensartinib 2Whole-Body Irradiation 2Vemurafenib 2Rituximab 2Mycophenolic Acid 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytosis, Langerhans-Cell × Whole-Body Irradiation × Clear all
NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡